Condition: Mpox · Sponsor: University of Birmingham
The MPXV CARE study principally aims to use clinical and epidemiology data to target specific individuals willing and able to provide appropriate and proportionate biological samples to develop novel immune diagnostics that support models of disease burden and future vaccine utilisation.
This description comes directly from the study's public registry record.
Shema Hugor · +250 791 207 333 · h.shema@cleancooling.org
Karishma Gokani · k.gokani@bham.ac.uk
Always discuss trial participation with your own doctor first.
| Rwanda Biomedical Center | Kigali, Rwanda | Recruiting |
Get one email when the public record changes — results posted, or the study's status changes. Nothing else, ever.
We email about this public record only. Unsubscribe anytime with one click. Never medical advice.
This page is independently generated by Eichor from the public ClinicalTrials.gov record and re-synced daily. It is not the sponsor's official website unless claimed. Nothing here is medical advice; eligibility is always determined by the study team — talk to your own doctor first.
Source record: clinicaltrials.gov/study/NCT06887556